Epigenetic mechanisms might be involved in Alzheimer's disease (AD). Genetic polymorphisms in several genes, including APOE (Apolipoprotein E), PSEN1 (Presenilin 1), CR1 (Complement receptor 1), and PICALM (Phosphatidylinositol binding clathrin assembly protein), have been associated to an increased AD risk. However, data regarding methylation of these specific genes are lacking. We evaluated DNA methylation measured by quantitative bisulfite-PCR pyrosequencing in 43 AD patients and 38 healthy subjects (HS). In a multivariate age- and gender-adjusted model, PICALM methylation was decreased in AD compared to HS (mean = 3.54 and 4.63, respectively, p = 0.007). In AD, PICALM methylation level was also positively associated to Mini-Mental Scale Examination (MMSE) score (percent change 3.48%, p = 0.008). Moreover, a negative association between PICALM methylation and age was observed only in HS (percent change - 2.29%, p = 0.002). In conclusion, our data suggest a possible role of PICALM methylation in AD, particularly related to cognitive function. Given the small study sample and the associative nature of our study, further prospective investigations are required to assess the dynamics of DNA methylation in the early stages of AD development.

PICALM gene methylation in blood of Alzheimer's disease patients is associated with cognitive decline / R. Mercorio, L. Pergoli, D. Galimberti, C. Favero, M. Carugno, E. Dalla Valle, F. Barretta, F. Cortini, E. Scarpini, V. Bollati, A.C. Pesatori. - In: JOURNAL OF ALZHEIMER'S DISEASE. - ISSN 1387-2877. - 65:1(2018), pp. 283-292. [10.3233/JAD-180242]

PICALM gene methylation in blood of Alzheimer's disease patients is associated with cognitive decline

R. Mercorio;L. Pergoli;D. Galimberti;C. Favero;M. Carugno;E. Dalla Valle;F. Barretta;F. Cortini;E. Scarpini;V. Bollati;A.C. Pesatori
2018

Abstract

Epigenetic mechanisms might be involved in Alzheimer's disease (AD). Genetic polymorphisms in several genes, including APOE (Apolipoprotein E), PSEN1 (Presenilin 1), CR1 (Complement receptor 1), and PICALM (Phosphatidylinositol binding clathrin assembly protein), have been associated to an increased AD risk. However, data regarding methylation of these specific genes are lacking. We evaluated DNA methylation measured by quantitative bisulfite-PCR pyrosequencing in 43 AD patients and 38 healthy subjects (HS). In a multivariate age- and gender-adjusted model, PICALM methylation was decreased in AD compared to HS (mean = 3.54 and 4.63, respectively, p = 0.007). In AD, PICALM methylation level was also positively associated to Mini-Mental Scale Examination (MMSE) score (percent change 3.48%, p = 0.008). Moreover, a negative association between PICALM methylation and age was observed only in HS (percent change - 2.29%, p = 0.002). In conclusion, our data suggest a possible role of PICALM methylation in AD, particularly related to cognitive function. Given the small study sample and the associative nature of our study, further prospective investigations are required to assess the dynamics of DNA methylation in the early stages of AD development.
Alzheimer's disease; epigenetics; methylation; Mini-Mental State Examination; PICALM; Neuroscience (all); Clinical Psychology; Geriatrics and Gerontology; Psychiatry and Mental Health
Settore MED/44 - Medicina del Lavoro
2018
Article (author)
File in questo prodotto:
File Dimensione Formato  
jad_2018_65-1_jad-65-1-jad180242_jad-65-jad180242.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 147.54 kB
Formato Adobe PDF
147.54 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/615776
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 12
social impact